Gene and cell therapy using cell fusion technology
US-11998617-B2 · Jun 4, 2024 · US
US2025313598A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2025313598-A1 |
| Application number | US-202519069405-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 4, 2025 |
| Priority date | Jun 28, 2017 |
| Publication date | Oct 9, 2025 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to polypeptides having trehalase activity, particularly derived from Talaromyces . The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides for the production of ethanol.
Opening claim text (preview).
1 . A polypeptide having trehalase activity, selected from the group consisting of: (a) a polypeptide having at least 93% sequence identity to the mature polypeptide of SEQ ID NO: 21 or at least 70% sequence identity to the mature polypeptide of SEQ ID NO: 23; (b) a polypeptide encoded by a polynucleotide having at least 95% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 20 or the cDNA sequence thereof; or at least 80% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 22 or the cDNA sequence thereof; (c) a variant of the mature polypeptide of SEQ ID NO: 21 or SEQ ID NO: 23 comprising a substitution, deletion, and/or insertion at one or more positions; and (d) a fragment of the polypeptide of (a), (b), or (c), that has trehalase activity. 2 . The polypeptides of claim 1 , having a thermal denaturing temperature, Td, determined by TSA of at least 60° C., at least 61° C., at least 62° C., at least 63° C., at least 64° C., at least 65° C., at least 66° C., at least 67° C., or at least 68° C. 3 . A composition comprising the polypeptide of claim 1 . 4 . A whole broth formulation or cell culture composition comprising the polypeptide of claim 1 . 5 . A polynucleotide encoding the polypeptide of claim 1 . 6 . A nucleic acid construct or expression vector comprising the polynucleotide of claim 5 operably linked to one or more heterologous control sequences that direct the production of the polypeptide in an expression host. 7 . A recombinant host cell comprising the nucleic acid construct claim 6 . 8 . The recombinant host cell of claim 7 , wherein the cell is a yeast cell. 9 . A method of producing a polypeptide having trehalase activity, comprising cultivating the host cell of claim 7 under conditions conducive for production of the polypeptide. 10 . A process of producing a fermentation product, comprising (a) liquefying a starch-containing material with an alpha-amylase; optionally pre-saccharifying the liquefied material before step (b); (b) saccharifying the liquefied material; (c) fermenting using a fermentation organism; wherein i) a glucoamylase; ii) a trehalase of claim 1 ; iii) optionally a cellulolytic enzyme composition and/or a protease; are present and/or added during saccharification step (b); fermentation step (c); simultaneous saccharification and fermentation; optionally presaccharification step before step (b). 11 . (canceled) 12 . (canceled) 13 . The process of claim 10 , wherein the fermenting organism is derived from a strain of Saccharomyces cerevisae. 14 . The process according to any of the claims 10 - 13 , wherein the yeast fermenting organism expresses the trehalase according to claim 1 . 15 . A process of producing fermentation products from starch-containing material comprising: (i) saccharifying a starch-containing material at a temperature below the initial gelatinization temperature; and (ii) fermenting using a fermentation organism; wherein saccharification and/or fermentation is done in the presence of the following enzymes: glucoamylase, alpha-amylase, trehalase of claim 1 , and optionally a protease and/or a cellulolytic enzyme composition. 16 . The recombinant host cell of claim 8 , which is a Candida, Hansenula, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces , or Yarrowia cell. 17 . The recombinant host cell of claim 8 , which is a Kluyveromyces lactis, Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis, Saccharomyces oviformis , or Yarrowia lipolytica cell. 18 . The recombinant host cell of claim 8 , which is a Saccharomyces cerevisiae cell.
Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title
Alpha-amylase (3.2.1.1) · CPC title
for yeasts · CPC title
acting on alpha -1,4-glucosidic bonds · CPC title
Alpha,alpha-phosphotrehalase (3.2.1.93) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.